Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
13 mpdn pulse + PDN + MTX----1件: 50 💬
2Actemra +MTX----1件: 46 💬
3Combination OF minocycline and MTX or MTX alone----1件: 46 💬
4ETN+MTX----1件: 46 💬
5FBL-MTX----1件: 46 💬
6HS628+MTX----1件: 46 💬
7Infliximab (INF) + MTX, DB1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
8Infliximab and MTX1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
9JNJ-38518168 / MTX----1件: 46 💬
10JNJ-39758979 / MTX1件: JNJ-39758979---1件: 46 💬
11Methotrexate (MTX)1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬1件: 46 💬
12MTX----14件: 13, 35, 40, 46, 49, 50, 51, 54, 55, 60, 84, 96, 107, 162 💬
13MTX 12.5----1件: 97 💬
14MTX 25----1件: 97 💬
15MTX discontinuation----7件: 46, 49, 50, 51, 53, 56, 107 💬
16MTX goldshield tablets----1件: 46 💬
17MTX hexal 2,5 MG tabletten----1件: 46 💬
18MTX hexal 2,5MG tabletten----1件: 46 💬
19MTX hexal tablets----1件: 46 💬
20MTX maintain----7件: 46, 49, 50, 51, 53, 56, 107 💬
21MTX plus ANTI-TNF----1件: 46 💬
22MTX S.C or IM and silymarin 140 MG TAB----1件: 46 💬
23MTX SC or IM----1件: 46 💬
24MTX start----1件: 46 💬
25MTX therapy----1件: 46 💬
26MTX-463----1件: 85 💬
27MTX-hold----1件: 46 💬
28OLE BSA adalimumab +/- MTX----1件: 107 💬
29OLE FD adalimumab +/- MTX----1件: 107 💬
30Phase 2: optional ETN, SSZ, HCQ, MTX----1件: 46 💬
31PLA + MTX switched TO ABA+ MTX, DB----1件: 46 💬
32RC18 160 MG plus MTX----1件: 46 💬
33Rituximab, MTX, folic acid1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
34Treatment OF MTX and HCQ----1件: 46 💬
35Treatment OF MTX and twhf----1件: 46 💬